Alliance shows belief in ultrasound with Molecular Biosystems purchase
This article was originally published in Clinica
Executive Summary
Following more than a year of negotiation, Alliance Pharmaceutical has reached agreement to acquire Molecular Biosystems (MBI) for around $10 million in shares.